Related Experiment Video

Updated: Mar 24, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.6K

[POSSIBLE CAUSES OF INEFFICIENT MONOTHERAPY OF SUBCLINICAL HYPOTHYROIDISM WITH L-THYROXIN]

A V Budnevsky, A Ya Kravchenko, E S Drobysheva

    Klinicheskaia Meditsina
    |March 12, 2016
    PubMed

    Insights

    Levothyroxine therapy for subclinical hypothyroidism is standard but may not normalize all metabolic parameters. This study explores reasons for treatment failure to improve therapeutic strategies.

    Area of Science:

    • Endocrinology
    • Metabolic Disorders

    Context:

    • Subclinical hypothyroidism treatment guidelines recommend L-thyroxine.
    • L-thyroxine replacement therapy is the established standard of care.

    Purpose:

    • To investigate the underlying mechanisms of L-thyroxine therapy failure in subclinical hypothyroidism.
    • To identify factors contributing to incomplete metabolic normalization.
    • To inform potential adjustments in therapeutic strategies.

    Summary:

    • L-thyroxine therapy, while standard for subclinical hypothyroidism, frequently fails to normalize all metabolic markers.
    • Analysis of data is needed to understand the reasons behind this therapeutic limitation.
    • Identifying these mechanisms is crucial for optimizing patient outcomes.

    Impact:

    • This research aims to refine treatment protocols for subclinical hypothyroidism.
    • Improved therapeutic strategies could lead to better metabolic control in affected patients.
    • Findings may guide future clinical practice and research in thyroid hormone replacement.

    More Related Videos

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis05:41

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

    Published on: February 9, 2024

    1.2K
    Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration10:19

    Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

    Published on: November 10, 2014

    26.5K

    Related Concept Videos

    Synthesis and Regulation of Thyroid Hormones01:20

    Synthesis and Regulation of Thyroid Hormones

    Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
    Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
    8.8K
    Functions of Thyroid Hormones01:18

    Functions of Thyroid Hormones

    The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
    TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
    6.5K
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
    324
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    333
    Therapeutic Drug Monitoring: Overview and Classification01:16

    Therapeutic Drug Monitoring: Overview and Classification

    Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
    506
    Desensitization and Tachyphylaxis01:20

    Desensitization and Tachyphylaxis

    Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
    3.4K